$176 Million is the total value of Euclidean Capital LLC's 11 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 30.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PMVP | Sell | PMV PHARMACEUTICALS INC | $53,983,000 | -34.6% | 2,336,909 | -15.6% | 30.69% | -23.5% |
| FHTX | FOGHORN THERAPEUTICS INC | $28,845,000 | +64.2% | 1,261,261 | 0.0% | 16.40% | +92.0% | |
| ALEC | ALECTOR INC | $20,255,000 | -9.5% | 980,894 | 0.0% | 11.52% | +5.8% | |
| TENAYA THERAPEUTICS INC | $17,353,000 | -8.2% | 915,705 | 0.0% | 9.87% | +7.3% | ||
| RAPT | Sell | RAPT THERAPEUTICS INC | $15,900,000 | -19.4% | 432,900 | -31.8% | 9.04% | -5.7% |
| NGM | Sell | NGM BIOPHARMACEUTICALS INC | $13,224,000 | -24.4% | 746,674 | -10.3% | 7.52% | -11.6% |
| ORIC | Sell | ORIC PHARMACEUTICALS INC | $10,989,000 | -32.4% | 747,550 | -3.8% | 6.25% | -20.9% |
| Sell | SURROZEN INC | $5,171,000 | -9.0% | 802,964 | -0.0% | 2.94% | +6.4% | |
| MQ | New | MARQETA INC | $4,254,000 | – | 247,752 | +100.0% | 2.42% | – |
| FFBC | FIRST FINL BANCORP OH | $4,232,000 | +4.2% | 173,576 | 0.0% | 2.41% | +21.8% | |
| VIR | New | VIR BIOTECHNOLOGY INC | $1,686,000 | – | 40,257 | +100.0% | 0.96% | – |
| PDD | Exit | PINDUODUO INCsponsored ads | $0 | – | -12,262 | -100.0% | -0.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PMV PHARMACEUTICALS INC | 12 | Q3 2023 | 54.4% |
| FOGHORN THERAPEUTICS INC | 12 | Q3 2023 | 16.4% |
| NGM BIOPHARMACEUTICALS INC | 12 | Q3 2023 | 14.5% |
| ALECTOR INC | 12 | Q3 2023 | 11.5% |
| RAPT THERAPEUTICS INC | 12 | Q3 2023 | 9.7% |
| ORIC PHARMACEUTICALS INC | 12 | Q3 2023 | 10.0% |
| TENAYA THERAPEUTICS INC | 9 | Q3 2023 | 9.9% |
| FIRST FINL BANCORP OH | 9 | Q4 2022 | 3.9% |
| SURROZEN INC | 9 | Q3 2023 | 2.9% |
| 23ANDME HOLDING CO | 7 | Q3 2023 | 27.2% |
View Euclidean Capital LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. | February 14, 2022 | 2,336,909 | 5.1% |
View Euclidean Capital LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2023-12-01 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Euclidean Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.